Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study

Mijin Kim, Meihua Jin, Min Ji Jeon, +6

Thyroid

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas

Meihua Jin, Dong Eun Song, Jonghwa Ahn, +5

Cancers

Immune Profiling of Advanced Thyroid Cancers Using Fluorescent Multiplex Immunohistochemistry

Jonghwa Ahn, Meihua Jin, Eyun Song, +5

Thyroid

Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea

Meihua Jin, Hye In Kim, Jeonghoon Ha, +2

Thyroid

ITGB4 Serves as an Identification and Prognosis Marker Associated with Immune Infiltration in Small Cell Lung Carcinoma

Guosheng Li, Zhi‐Guang Huang, Rong‐Quan He, +14

Molecular Biotechnology

The tissue distribution and significance of B7-H4 in laryngeal carcinoma

Lili Chen, Meihua Jin, Chunshi Li, +2

Oncotarget

ImmunologyImmunoeditingPathologyImmunotherapyTumor Biology +15

Characterization of variations in IL23A and IL23R genes: possible roles in multiple sclerosis and other neuroinflammatory demyelinating diseases

Fei-Feng Li, Xidong Zhu, Peng Yan, +5

Aging

Clinical significance of cyclin-dependent kinase inhibitor 2C expression in cancers: from small cell lung carcinoma to pan-cancers

Guosheng Li, Gang Chen, Jun Liu, +13

BMC Pulmonary Medicine

Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort

Meihua Jin, Ahreum Jang, Chae A Kim, +5

European Thyroid Journal

SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer

Meihua Jin, Woo Kyung Lee, Mi‐Hyeon You, +5

Endocrine Connections